The Sanfilippo Foundation Switzerland is organising a congress at the Geneva International Conference Centre (CICG) from the 8th to 10th of December 2011. The congress theme is « Research towards a treatment for Mucopolysaccharidosis (MPS) ».

Themes to be covered during the meeting with respective speakers:

1. Substrate Reduction Therapy
Zaccharon Pharmaceuticals Inc. (USA), MPS I, II, III

2. Chemical Chaperone Therapy
Prof. Mathieu Sollogoub, Paris, (France) MPS III B
Prof. Tanja Wrodnigg, Graz, (Austria), Morquio B/ Gaucher
Prof. Martin Olivier, Orléans, (France) MPS IVB, MPS VII
Prof. Alexey Pshezhetsky Montreal, (Canada) MPSIII C

3. Enzyme Replacement Therapy
Dr. Patrick Haslett, Shire Pharmaceuticals (UK) (Keynote)
Dr. Maurizio Scarpa, Padova, (Italy)

4. Genetic Therapy/Bone Marrow Transplantation
Prof. Marc Tardieu, Paris (France) (Keynote)
Prof. Jean-Michel Heard, Paris (France), MPS III B, Hurler
Prof. John Hopwood, Adélaide (Australia) (Keynote)
Dr. Dao Pan, Cincinnati (USA)

5. Alternative approaches for treating MPS
Prof. Lena Kjellén, Uppsala, (Sweden) (Keynote)
Prof. Marco Sardiello, Texas (USA) and Naples (Italy).
Prof G. Wegrzyn, Gdansk, (Poland).
Prof. Brian Bigger, Manchester, (UK)
Prof. Thomas Jensen , Orphazyme (NL)

6. The forgotten MPS: Sly, Morquio, Maroteaux -Lamy syndrome
Prof. Tanja Wrodnigg, Graz (Austria), Morquio B
Prof. Maurizio Scarpa, Padova, (Italy) Maroteaux-Lamy

7. Clinical care/Case studies

8. Family Experiences


View PDF

More details

Find an actor

4à6 de BioAlps - Selexis SA20.09.2017

Les "4à6" de BioAlps sont une série d'événements organisés dans chacun des 7 cantons de Suisse occidentale.

Welcome To Health Valley

Building on skills honed over the centuries, western Switzerland has become a world leader in biotech.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn